Pillstats
Rx only · Solution · Oral

Brivaracetam

Brands: Briviact · Brivaracetam

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1739745
US makers6 labelers
Packages6
DEA / ScheduleCV

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.39$2.77$4.16$5.54Dec 2025May 2026Jul 2026
$1.176
Latest avg · Jul 22, 2026
-75%
Since Dec 17, 2025
6
Active US suppliers
33%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5.6K11K17K23K2025 Q12025 Q22025 Q32025 Q42026 Q1
20K
Rx · 2026 Q1
7.1M
Units dispensed
+12%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novadoz Pharmaceuticals LLCunknown1SUPPLYING
Zhejiang Poly Pharm. Co., Ltd.unknown1SUPPLYING
PAI Holdings, LLC dba PAI Pharmaunknown1SUPPLYING
UCB, Inc.unknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown1SUPPLYING
Ascend Laboratories, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.